CHA News Article

FDA Releases Statement on Fungal Meningitis Outbreak

The Food and Drug Administration (FDA) has released a statement advising all health care providers who received injectable products from the New England Compounding Center (NECC) to follow up with patients who were given any of those products. These include any ophthalmic drug that is injectable or used in conjunction with eye surgery, or a cardioplegic solution purchased from or produced by NECC after May 21, 2012. For more information, see the FDA statement, which is linked below. Updates on the investigation and outbreak are available on the Centers for Disease Control and Prevention website at